Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04270747
Brief Title: A Study to Understand Effectiveness and Safety of ABP 938 Compared to Aflibercept (Eylea®) in Patients Suffering With Neovascular Age-related Macular Degeneration [Neovascular (Wet) AMD]

First Submitted : February 13, 2020
First Submitted that Met QC Criteria : February 13, 2020
First Posted : February 17, 2020

Last Update Submitted that Met QC Criteria : July 7, 2021
Last Update Posted : July 8, 2021